Fifth Third Bancorp Abb Vie Inc. Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Abb Vie Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 1,619,206 shares of ABBV stock, worth $272 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

1,619,206

Previous 1,622,079 0.18%

Holding current value

$272 Million

Previous $278 Million 14.93%

% of portfolio

1.17%

Previous 1.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$163.84 - $199.33 $470,712 - $572,675	-2,873 Reduced 0.18%	1,619,206 $320 Million
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $3.79 Million - $4.42 Million	-24,463 Reduced 1.49%	1,622,079 $278 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $1.48 Million - $1.69 Million	9,254 Added 0.57%	1,646,542 $300 Million
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $4.15 Million - $4.67 Million	-30,159 Reduced 1.81%	1,637,288 $254 Million
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $112,616 - $130,369	843 Added 0.05%	1,667,447 $249 Million
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $2.27 Million - $2.82 Million	17,130 Added 1.04%	1,666,604 $225 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $4.56 Million - $5.26 Million	-31,566 Reduced 1.88%	1,649,474 $263 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $7.01 Million - $8.41 Million	50,702 Added 3.11%	1,681,040 $0
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $359,951 - $412,840	2,682 Added 0.16%	1,630,338 $219 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $5.6 Million - $7.13 Million	40,728 Added 2.57%	1,627,656 $249 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $2.22 Million - $2.75 Million	-16,783 Reduced 1.05%	1,586,928 $257 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $4.72 Million - $5.97 Million	43,942 Added 2.82%	1,603,711 $217 Million
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $6.97 Million - $7.92 Million	65,548 Added 4.39%	1,559,769 $168 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $6.33 Million - $7.06 Million	-60,201 Reduced 3.87%	1,494,221 $168 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $5.18 Million - $5.71 Million	50,671 Added 3.37%	1,554,422 $168 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $4.54 Million - $6.13 Million	56,448 Added 3.9%	1,503,751 $161 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $3.47 Million - $4.07 Million	40,361 Added 2.87%	1,447,303 $127 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $9.76 Million - $13.1 Million	132,957 Added 10.44%	1,406,942 $138 Million
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $4.53 Million - $6.87 Million	70,234 Added 5.83%	1,273,985 $97.1 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $5.52 Million - $6.91 Million	76,561 Added 6.79%	1,203,751 $107 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $2.65 Million - $3.18 Million	41,999 Added 3.87%	1,127,190 $85.4 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $667,183 - $852,816	-10,155 Reduced 0.93%	1,085,191 $78.9 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $15 Million - $17.7 Million	-194,691 Reduced 15.09%	1,095,346 $88.3 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $389 - $480	-5 Reduced -0.0%	1,290,037 $119 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $11.4 Million - $12.7 Million	-128,657 Reduced 9.07%	1,290,042 $122 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $4.08 Million - $4.82 Million	45,409 Added 3.31%	1,418,699 $131 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $2.71 Million - $3.63 Million	29,441 Added 2.19%	1,373,290 $130 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $6.29 Million - $6.89 Million	-70,195 Reduced 4.96%	1,343,849 $130 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $1.84 Million - $2.35 Million	26,289 Added 1.89%	1,414,044 $126 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,387,755	1,387,755 $101 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Abb Vie Inc. Transaction History